Recommendation MAI-49: Review analgesia rollout to HART operatives
From Manchester Arena Inquiry: Volume 2: Emergency Response, published 3 November 2022.
Recommendation
If the decision is that the regulatory regime should be altered in this way, the National Ambulance Resilience Unit should consider urgently whether the use of such analgesia should be rolled out to all Hazardous Area Response Team and other specialist operatives, as part of their basic equipment, and to paramedics more generally.
In brief (written by this site)
The Cabinet Office reported in February 2026 that delivery remained in progress, stating that once regulatory requirements are confirmed, the proposal is to roll out analgesia "in a phased approach" as more evidence is reviewed (Cabinet Office, Feb 2026). It noted that confirming regulatory requirements and reviewing evidence across patient groups remain outstanding before rollout can proceed (Cabinet Office, Feb 2026). The UK Government accepted the recommendation in full in November 2025, having initially set out this phased plan (Cabinet Office response, Nov 2025; Cabinet Office, Nov 2025).
AI-generated summary of the record on this page, checked by a second model and automatic checks, 26 Sep 2026. The record below is the sources' own words.
Government response
Accepted in full
Delivery
Cabinet Office says in progress (27 February 2026)
Once regulatory requirements are confirmed, the proposal is to roll out in a phased approach as more evidence in relation to use in different patient groups reviewed.
Earlier statement on delivery (1)
Cabinet Office (14 November 2025)
Once regulatory requirements are confirmed, the proposal is to roll out in a phased approach as more evidence in relation to use in different patient groups reviewed.
From: Manchester Arena Inquiry Recommendations Dashboard, original version (data file)
Source
Responsible bodies
Themes and tags
Who has spoken
- UK Government
Response - Cabinet Office
Delivery statement